Harris G. Yfantis

3.8k total citations · 1 hit paper
36 papers, 2.8k citations indexed

About

Harris G. Yfantis is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Harris G. Yfantis has authored 36 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Harris G. Yfantis's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Harris G. Yfantis is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Harris G. Yfantis collaborates with scholars based in United States, Germany and Australia. Harris G. Yfantis's co-authors include Stefan Ambs, Robert M. Stephens, Ming Yi, Robyn L. Prueitt, Tiffany M. Howe, Tiffany A. Wallace, Robert Hudson, Carlo M. Croce, Dong Hoon Lee and George A. Calin and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Harris G. Yfantis

36 papers receiving 2.7k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer

2008 591 citations Stefan Ambs, Robyn L. Prueitt et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harris G. Yfantis United States	20	1.7k	1.3k	662	474	341	36	2.8k
Xiangjian Luo China	31	1.8k 1.1×	1.2k 0.9×	726 1.1×	279 0.6×	353 1.0×	71	2.9k
Liwen Xu China	22	2.0k 1.2×	816 0.6×	635 1.0×	851 1.8×	634 1.9×	64	3.3k
Francesca Pentimalli Italy	38	2.3k 1.4×	922 0.7×	1.1k 1.6×	429 0.9×	252 0.7×	120	3.8k
Ádám Nagy Hungary	17	2.8k 1.7×	1.5k 1.1×	1000 1.5×	980 2.1×	542 1.6×	28	4.0k
Yu‐Shui Ma China	31	1.9k 1.2×	1.3k 1.0×	619 0.9×	339 0.7×	332 1.0×	117	3.0k
Tongsen Zheng China	30	1.8k 1.1×	1.1k 0.8×	876 1.3×	466 1.0×	688 2.0×	63	3.2k
Xuanmao Jiao United States	30	1.8k 1.1×	655 0.5×	1.3k 2.0×	251 0.5×	540 1.6×	58	3.0k
Raphael A. Nemenoff United States	34	1.5k 0.9×	654 0.5×	1.0k 1.5×	495 1.0×	1.0k 3.1×	75	3.4k
Nayiyuan Wu China	24	1.7k 1.1×	1.1k 0.8×	742 1.1×	557 1.2×	426 1.2×	84	2.9k

Countries citing papers authored by Harris G. Yfantis

Since Specialization

Citations

This map shows the geographic impact of Harris G. Yfantis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harris G. Yfantis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harris G. Yfantis more than expected).

Fields of papers citing papers by Harris G. Yfantis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harris G. Yfantis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harris G. Yfantis. The network helps show where Harris G. Yfantis may publish in the future.

Co-authorship network of co-authors of Harris G. Yfantis

This figure shows the co-authorship network connecting the top 25 collaborators of Harris G. Yfantis. A scholar is included among the top collaborators of Harris G. Yfantis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harris G. Yfantis. Harris G. Yfantis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Panigrahi, Gatikrushna, Julián Candia, Tiffany H. Dorsey, et al.. (2023). Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiency. JCI Insight. 8(23). 8 indexed citations

Tang, Wei, Tiffany H. Dorsey, Harris G. Yfantis, et al.. (2023). Population-specific Mutation Patterns in Breast Tumors from African American, European American, and Kenyan Patients. Cancer Research Communications. 3(11). 2244–2255. 11 indexed citations

Xie, Guofeng, et al.. (2022). Zinc finger protein 277 is an intestinal transit-amplifying cell marker and colon cancer oncogene. JCI Insight. 7(4). 19 indexed citations

Yfantis, Harris G., et al.. (2020). Iron pill induced gastritis causing severe anemia. Clinical Journal of Gastroenterology. 13(5). 732–735. 2 indexed citations

Zhang, Yongrong, Zhiyong Yang, Si Gao, et al.. (2017). The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model. Anaerobe. 48. 249–256. 12 indexed citations

Yang, Shouhui, Peijun He, Aaron J. Schetter, et al.. (2016). Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer. Clinical Cancer Research. 22(24). 5992–6001. 40 indexed citations

Zhang, Geng, Peijun He, Anuradha Budhu, et al.. (2013). Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer. Clinical Cancer Research. 19(18). 4983–4993. 245 indexed citations

Zhang, Geng, Peijun He, Jochen Gaedcke, et al.. (2013). FOXL1, a Novel Candidate Tumor Suppressor, Inhibits Tumor Aggressiveness and Predicts Outcome in Human Pancreatic Cancer. Cancer Research. 73(17). 5416–5425. 37 indexed citations

Soliman, Hatem, Bhupendra Rawal, Ji‐Hyun Lee, et al.. (2013). Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry. Cancer Immunology Immunotherapy. 62(5). 829–837. 73 indexed citations

10.

Jain, Ajay, Bhawna Poonia, Edward So, et al.. (2013). Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancer. European Journal of Cancer. 49(15). 3344–3352. 7 indexed citations

11.

Sohn, Jane J., Aaron J. Schetter, Harris G. Yfantis, et al.. (2012). Macrophages, Nitric Oxide and microRNAs Are Associated with DNA Damage Response Pathway and Senescence in Inflammatory Bowel Disease. PLoS ONE. 7(9). e44156–e44156. 56 indexed citations

12.

Zhang, Geng, Aaron J. Schetter, Peijun He, et al.. (2012). DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma. PLoS ONE. 7(2). e31507–e31507. 191 indexed citations

13.

Funamizu, Naotake, Chaoxin Hu, Curtis Lacy, et al.. (2012). Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma. International Journal of Cancer. 132(4). 785–794. 104 indexed citations

14.

Glynn, Sharon A., Robyn L. Prueitt, Lisa A. Ridnour, et al.. (2010). COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer. BMC Cancer. 10(1). 626–626. 59 indexed citations

15.

Ambs, Stefan, Robyn L. Prueitt, Ming Yi, et al.. (2008). Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer. Cancer Research. 68(15). 6162–6170. 591 indexed citations breakdown →

16.

Wallace, Tiffany A., Robyn L. Prueitt, Ming Yi, et al.. (2008). Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men. Cancer Research. 68(3). 927–936. 386 indexed citations

17.

Traub, Richard J., et al.. (2008). A Rat Model of Chronic Postinflammatory Visceral Pain Induced by Deoxycholic Acid. Gastroenterology. 135(6). 2075–2083. 60 indexed citations

18.

Prueitt, Robyn L., Brenda J. Boersma, Tiffany M. Howe, et al.. (2006). Inflammation and IGF‐I activate the Akt pathway in breast cancer. International Journal of Cancer. 120(4). 796–805. 77 indexed citations

19.

Nonaka, Daisuke, et al.. (2002). Pseudallescheriasis as an Aggressive Opportunistic Infection in a Bone Marrow Transplant Recipient. Archives of Pathology & Laboratory Medicine. 126(2). 207–209. 9 indexed citations

20.

Yfantis, Harris G., Daisuke Nonaka, Rudy J. Castellani, Christopher Harman, & Chen Sun. (2002). Heterogeneity in fetal akinesia deformation sequence (FADS): autopsy confirmation in three 20–21‐week fetuses. Prenatal Diagnosis. 22(1). 42–47. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact